# Talzenna

NDC: 63539-025
Generic name: talazoparib
Labeler / Manufacturer: U.S. Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, LIQUID FILLED
Routes: ORAL
Marketing started: 20240709

FDA application: NDA217439

## Active ingredients

- TALAZOPARIB TOSYLATE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63539-025"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63539-025
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b653221e-971f-4452-92d4-797924f1ff59